Jonathan Anderman - Feb 11, 2025 Form 4 Insider Report for Compass Therapeutics, Inc. (CMPX)

Role
Sr VP, Gen Counsel & Corp Sec
Signature
/s/ Neil Lerner attorney-in-fact
Stock symbol
CMPX
Transactions as of
Feb 11, 2025
Transactions value $
$0
Form type
4
Date filed
2/13/2025, 05:09 PM
Previous filing
Aug 14, 2024
Next filing
Apr 8, 2025
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CMPX Stock Option (Right to Buy) Award $0 +280K $0.00 280K Feb 11, 2025 Common Stock 280K $3.65 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The options vest over 48 substantially equal monthly installments starting March 11, 2025.